Increased lysophosphatidylcholine and non-esterified fatty acid content in LDL induces chemokine release in endothelial cells: Relationship with electronegative LDL

Atherosclerosis

Volumn 177, Issue 2, 2004, Pages 299-305

  Benítez, Sònia ^a   Camacho, Mercedes ^b   Arcelus, Rosa ^a   Vila, Luís ^b   Bancells, Cristina ^a   Ordóñez Llanos, Jordi ^a   Sánchez Quesada, José Luis ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Chemokines; Electronegative LDL; Inflammation; Lysophosphatidylcholine; Non esterified fatty acids

Indexed keywords

ALKADIENE; ANTIOXIDANT; CHEMOKINE; FATTY ACID; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPASE A2;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CHEMICAL MODIFICATION; CONCENTRATION (PARAMETERS); CONJUGATION; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTRICITY; ENDOTHELIUM CELL; ENZYME RELEASE; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; TECHNIQUE; UMBILICAL VEIN;

CHEMOKINE CCL2; CHEMOKINES; CHROMATOGRAPHY, ION EXCHANGE; ENDOTHELIAL CELLS; FATTY ACIDS, NONESTERIFIED; HUMANS; INTERLEUKIN-8; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES;

EID: 8644239488     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.07.027     Document Type: Article

References (43)

1. M. Navab, J.A. Berliner, and A.D. Watson The Yin and Yang of oxidation in the development of the fatty streak Arterioscler Thromb Vasc Biol 16 1996 831 842
2. JA Berliner, M. Navab, and A.M. Fogelman Atherosclerosis: basic mechanisms. Oxidation, inflammation and genetics Circulation 91 1995 2488 2496
3. P. Avogaro, G. Bittolo-Bon, and G. Cazzolato Presence of a modified low density lipoprotein in humans Arteriosclerosis 8 1988 79 87
4. H. Shimano, N. Yamada, and S. Ishibashi Oxidation-labile subfraction of human plasma low-density lipoprotein isolated by ion-exchange chromatography J Lipid Res 32 1991 763 773
5. K. Nyyssönen, J. Kaikkonen, and J.T. Salonen Characterization and determinants of an electronegatively-charged low-density lipoprotein in human plasma Scand J Clin Lab Invest 56 1996 681 689
6. J.L. Sánchez-Quesada, H. Ortega, and A. Payés-Romero LDL from aerobically-trained subjects shows higher resistance to oxidative modification than LDL from sedentary subjects Atherosclerosis 132 1997 207 213
7. J.L. Sánchez-Quesada, C. Otal-Entraigas, and M. Franco Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with familial hypercholesterolemia Am J Cardiol 84 1999 655 659
8. J.L. Sánchez-Quesada, S. Benítez, and M. Franco Density distribution of electronegative LDL(LDL(-)) in normolipemic and hyperlipemic subjects J Lipid Res 43 2002 699 705
9. J.L. Sánchez-Quesada, A. Pérez, and A. Caixàs Electronegative low-density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control Diabetologia 39 1996 1469 1476
10. J.L. Sánchez-Quesada, A. Pérez, and A. Caixàs Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: nonenzymatic glycosylation and oxidative modifications J Clin Endocrinol Metab 86 2001 3243 3249
11. E. Moro, P. Alessandrini, and C. Zambon Is glycation of low density lipoproteins in patients with type 2 diabetes mellitus a pre-oxidative condition? Diabet Med 16 1999 663 669
12. O. Ziouzenkova, L. Asatryan, and M. Akmal Oxidative cross-linking of apoB100 and hemoglobin results in low density lipoproteins modification in blood J Biol Chem 27 1999 18916 18924
13. H.N. Hodis, D.M. Kramsch, and P. Avogaro Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low-density lipoprotein (electronegative LDL) J Lipid Res 35 1994 669 677
14. K. Demuth, I. Myara, and B. Chappey A cytotoxic electronegative LDL subfraction is present in human plasma Arterioscler Thromb Vasc Biol 16 1996 773 783
15. C. de Castellarnau, J.L. Sánchez-Quesada, and S. Benítez Electronegative LDL from normolipemic subjects induces IL-8 and monocyte chemotactic protein secretion by human endothelial cells Arterioscler Thromb Vasc Biol 20 2000 2281 2287
16. J.L. Sánchez-Quesada, M. Camacho, and R. Antón Electronegative LDL of FH subjects Chemical characterization and induction of chemokine release from human endothelial cells. Atherosclerosis 166 2003 261 270
17. A. Sevanian, G. Bittolo-Bon, and G. Cazzolato Electronegative LDL is a lipid hydroperoxide-enriched circulating lipoprotein J Lipid Res 38 1997 419 428
18. J. Greilberger, X. Wang, G. Ledinski, Q. Chen, and G. Jurgens Presence of aldehydic epitopes on a minor low density lipoprotein fraction Free Rad Biol Med 26 1999 1489 1494
19. R.J. Havel, H.A. Eder, and J.H. Bragdon The distribution and chemical composition of ultracentrifugally-separated lipoproteins in human serum J Clin Invest 34 1955 1345 1353
20. S. Benítez, J.L. Sánchez-Quesada, and L. Lucero Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acids Atherosclerosis 160 2002 223 232
21. J.K. Hakala, K. Öörni, M. Ala-Korpela, and P.T. Kovanen Lipolytic modification of LDL by phospholipase A2 induces particle aggregation in the absence and fusion in the presence of heparin Arterioscler Thromb Vasc Biol 19 1999 1276 1283
22. H. Esterbauer, G. Striegl, H. Puhl, and M. Rotheneder Continuous monitoring of in vitro oxidation of human low density lipoprotein Free Rad Res Commun 6 1989 67 75
23. K. Fukunaga, T. Suzuki, and K. Takama Highly sensitive high-performance liquid chromatography for the measurement of malondialdehyde in biological samples J Chromatogr 621 1993 77 81
24. G.M. Patton, and S.J. Robins Separation and quantitation of phospholipid classes by HPLC J.M. Ordovás Lipoprotein protocols 1998 Humana Press Totowa, New Jersey 193 216
25. E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can J Biochem Physiol 37 1959 911 914
26. J. Kowalski, B. Okopien, and A. Madej Levels of sICAM-1, sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and IIb Int J Clin Pharmacol Ther 39 2001 48 52
27. A. Rezaie-Majd, T. Maca, and R.A. Bucek Simvastatin reduces expression of cytokines interleukin-6, interleukin-8 and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients Arterioscler Thromb Vasc Biol 22 2002 1194 1199
28. C.H. Chen, T. Jiang, and J.H. Yang Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription Circulation 107 2003 2102 2108
29. C.Y. Yang, J.L. Raya, and H.H. Chen Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins Arterioscler Thromb Vasc Biol 23 2003 1083 1090
30. S. Benítez, Ordóñez-Llanos, and M. Franco Effect of simvastatin in familial hypercholesterolemia on the affinity of charge-differing low-density lipoprotein subfractions to the low-density lipoprotein receptor Am J Cardiol 93 2004 414 420
31. G.N. Rao, R.W. Alexander, and M.S. Runge Linoleic acid and its metabolites, hydroperoxyoctadecadienoic acids, stimulate c-Fos, c-Jun and c-Myc mRNA expression, mitogen-activated protein kinase activation, and growth in rat aortic smooth muscle cells J Clin Invest 96 1995 842 847
32. B. Henning, M. Toborek, and S. Joshi-Barve Linoleic acid activates nuclear transcription factor kB (NF-kB) and induces NF-kB-dependent transcription in cultured endothelial cells Am J Clin Nutr 63 1996 322 328
33. K. Sonoki, M. Iwase, and K. Iino Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor Metabolism 52 2003 308 314
34. P. Suriyaphol, D. Fenske, and U. Zähringer Enzymatically modified nonoxidized low density lipoprotein induces interleukin-8 in human endothelial cells. Role of free fatty acids. Circulation 106 2002 2581 2587
35. B.H. Chung, G.A. Tallis, Cho BHS, J.P. Segrest, and Y. Henkins Lipolysis-induced partitioning of free fatty acids to lipoproteins: effect on the biological properties of free fatty acids J Lipid Res 1995 36
36. T.J. Nevalainen, and J.M. Grönroos Serum phospholipase A2 in inflammatory diseases W. Uhl T.J. Nevalainen M.W. Buchler Phospholipase A2. Basic and clinical aspects in inflammatory diseases vol. 24 1997 Karger Basel 104 109
37. E. Hurt-Camejo, S. Anderssen, and R. Standal Localization of non-pancreatic secretory phospholipase A2 in normal and atherosclerotic arteries: activity of the isolated enzyme on low-density lipoprotein Arterioscler Thromb Vasc Biol 17 1997 300 309
38. E. Hurt-Camejo, G. Camejo, H. Peilot, K. Öörni, and P. Kovanen Phospholipase A2 in vascular disease Circ Res 89 2001 298 304
39. F.C. de Beer, M.C. de Beer, and D.R. van der Westhuyzen Secretory non-pancreatic phospholipase A2: influence on lipoprotein metabolism J Lipid Res 38 1997 2232 2239
40. P. Avogaro, G. Cazzolatto, and G. Bittolo-Bon Some questions concerning a small, more electronegative LDL circulating in human plasma Atherosclerosis 91 1991 163 171
41. D.M. Stafforini, T.M. McIntyre, G.A. Zimmerman, and S.M. Prescott Platelet-activating factor acetylhydrolases J Biol Chem 272 1997 17895 17898
42. C.H. Macphee, K.E. Moores, and H.F. Boyd Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor Biochem J 338 1999 479 487
43. S. Benítez, J.L. Sánchez-Quesada, and V. Ribas Platelet-activating factor acetylhydrolase (PAF-AH) is mainly associated with electronegative low-density lipoprotein subfraction Circulation 108 2003 92 96